Last reviewed · How we verify
Omeprazole Low dose
Omeprazole Low dose is a Small molecule drug developed by Damascus Hospital. It is currently FDA-approved.
Omeprazole Low Dose, marketed by Damascus Hospital, is a proton pump inhibitor with a well-established presence in the treatment of acid-related disorders. The key composition patent is set to expire in 2028, providing a period of exclusivity that supports current market stability. The primary risk lies in the potential increase in generic competition following the patent expiry, which could erode market share and revenue.
At a glance
| Generic name | Omeprazole Low dose |
|---|---|
| Sponsor | Damascus Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy (EARLY_PHASE1)
- A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer (PHASE3)
- Endoscopic Evidence of Maintenance of Healing With Oral NEXIUM in Patients 1 to 11 Years Old With Erosive Esophagitis. (PHASE3)
- Prospective Study of Frontline Antibiotics Therapy in the Treatment of Early-stage HP-negative Gastric MALT Lymphoma (PHASE2)
- A Study in Healthy Participants to Evaluate the Effects of Multiple Doses of JNJ-55308942 on Cytochrome P450 Substrate Activity and on the Pharmacokinetics of Levonorgestrel/Ethinyl Estradiol (PHASE1)
- Clinical Study on Strategy for Refractory Henoch-Schönlein Purpura (NA)
- Optimized Bismuth Quadruple Therapy vs Triple Standard Therapy for Helicobacter Pylori Eradication (PHASE4)
- Opioid Free vs. Standard Perioperative Pain Regimen for Anterior Cervical Discectomy and Fusion (ACDF) Surgery (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Omeprazole Low dose CI brief — competitive landscape report
- Omeprazole Low dose updates RSS · CI watch RSS
- Damascus Hospital portfolio CI
Frequently asked questions about Omeprazole Low dose
What is Omeprazole Low dose?
Who makes Omeprazole Low dose?
What development phase is Omeprazole Low dose in?
Related
- Manufacturer: Damascus Hospital — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing